477 related articles for article (PubMed ID: 33740988)
1. RNA-based therapies: A cog in the wheel of lung cancer defense.
Khan P; Siddiqui JA; Lakshmanan I; Ganti AK; Salgia R; Jain M; Batra SK; Nasser MW
Mol Cancer; 2021 Mar; 20(1):54. PubMed ID: 33740988
[TBL] [Abstract][Full Text] [Related]
2. Small RNAs and non-small cell lung cancer.
Tong AW
Curr Mol Med; 2006 May; 6(3):339-49. PubMed ID: 16712479
[TBL] [Abstract][Full Text] [Related]
3. A review on RNAi therapy for NSCLC: Opportunities and challenges.
Kumar V; Yadavilli S; Kannan R
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1677. PubMed ID: 33174364
[TBL] [Abstract][Full Text] [Related]
4. The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses.
Ciccone G; Ibba ML; Coppola G; Catuogno S; Esposito CL
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047090
[TBL] [Abstract][Full Text] [Related]
5. Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies.
Du X; Zhang J; Wang J; Lin X; Ding F
Curr Pharm Des; 2018 Feb; 23(39):5997-6010. PubMed ID: 28714414
[TBL] [Abstract][Full Text] [Related]
6. Long and short noncoding RNAs in lung cancer precision medicine: Opportunities and challenges.
Tian H; Zhou C; Yang J; Li J; Gong Z
Tumour Biol; 2017 Apr; 39(4):1010428317697578. PubMed ID: 28381159
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?
Yang H; Liu Y; Chen L; Zhao J; Guo M; Zhao X; Wen Z; He Z; Chen C; Xu L
Biomolecules; 2023 May; 13(6):. PubMed ID: 37371458
[TBL] [Abstract][Full Text] [Related]
8. Innovative developments and emerging technologies in RNA therapeutics.
Halloy F; Biscans A; Bujold KE; Debacker A; Hill AC; Lacroix A; Luige O; Strömberg R; Sundstrom L; Vogel J; Ghidini A
RNA Biol; 2022; 19(1):313-332. PubMed ID: 35188077
[TBL] [Abstract][Full Text] [Related]
9. Development of small RNA delivery systems for lung cancer therapy.
Fujita Y; Kuwano K; Ochiya T
Int J Mol Sci; 2015 Mar; 16(3):5254-70. PubMed ID: 25756380
[TBL] [Abstract][Full Text] [Related]
10. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
Najafi A; Tavallaei M; Hosseini SM
Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer and microRNAs: therapeutic impact.
Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E
Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296
[TBL] [Abstract][Full Text] [Related]
12. RNA interference in mammalian cell systems.
Lochmatter D; Mullis PE
Horm Res Paediatr; 2011; 75(1):63-9. PubMed ID: 21252559
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA let-7: Regulation, single nucleotide polymorphism, and therapy in lung cancer.
Yang G; Zhang W; Yu C; Ren J; An Z
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C1-6. PubMed ID: 26323902
[TBL] [Abstract][Full Text] [Related]
14. Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy.
Garbuzenko OB; Kuzmov A; Taratula O; Pine SR; Minko T
Theranostics; 2019; 9(26):8362-8376. PubMed ID: 31754402
[TBL] [Abstract][Full Text] [Related]
15. Short GC-rich RNA similar to miR 1909 and 1915 folds in silico with the 5'-UTR and ORF of Notch and responders: potential for the elimination of cancer stem cells.
Li Y; Mine T; Ioannides CG
Oncol Rep; 2010 Dec; 24(6):1443-53. PubMed ID: 21042738
[TBL] [Abstract][Full Text] [Related]
16. Critical microRNAs in Lung Cancer: Recent Advances and Potential Applications.
Zarredar H; Ansarin K; Baradaran B; Shekari N; Eyvazi S; Safari F; Farajnia S
Anticancer Agents Med Chem; 2018; 18(14):1991-2005. PubMed ID: 30088452
[TBL] [Abstract][Full Text] [Related]
17. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA as tools and therapeutics in lung cancer.
Barger JF; Nana-Sinkam SP
Respir Med; 2015 Jul; 109(7):803-12. PubMed ID: 25910758
[TBL] [Abstract][Full Text] [Related]
19. Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics.
Cuciniello R; Filosa S; Crispi S
J Exp Clin Cancer Res; 2021 Dec; 40(1):383. PubMed ID: 34863235
[TBL] [Abstract][Full Text] [Related]
20. Novel Therapeutic Approaches Targeting Post-Translational Modifications in Lung Cancer.
Baietti MF; Sewduth RN
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
